Laurantis Pharma Completes Funding Round
September 4, 2012: Laurantis Pharma completes funding round for research program First Human Trial of...
September 4, 2012: Laurantis Pharma completes funding round for research program First Human Trial of...
August 27, 2012: CellAegis Devices announces first clinical program to use the Company’s autoRIC™ Device...
July 18, 2012: CellAegis Devices, Inc., announced today that it has received a CE Mark...
July 9, 2012: CapriCor Inc. Announces FDA Approval To Initiate ALLSTAR Trial of Allogeneic Stem...
June 14, 2012: CardiAQ Valve Technologies (CardiAQ), which has developed the world’s first self-conforming and...
April 26, 2012: MiRagen Therapeutics, Inc., a biopharmaceutical company developing innovative microRNA (miRNA)-based therapeutics primarily...